Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NTLA
Recent news which mentions NTLA
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022
January 31, 2022
Tickers
ALGN
ARCT
AZEK
BAH
Tags
Upgrades
BYND
SDC
From
Benzinga
Analyst Ratings For Intellia Therapeutics
January 31, 2022
Tickers
NTLA
Tags
Benzinga
BZI/AAR
NTLA
From
Benzinga
A Deep Dive Into the Video Game Industry
January 29, 2022
Tickers
AAL
AAPL
AMZN
ATVI
Tags
VRTX
NFLX
AAPL
From
Motley Fool
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
Tickers
BNTX
CURLF
EDIT
GILD
Tags
BNTX
MSOS
Recent Press Releases
From
Motley Fool
5 Charts to Remember if the Stock Market Crashes in 2022
January 19, 2022
Tickers
CSCO
MRNA
NTLA
TSLA
Tags
CSCO
Recent Press Releases
TSLA
From
Motley Fool
Is Beam Therapeutics a Good Stock to Buy Now?
January 16, 2022
Tickers
BEAM
CRSP
NTLA
PFE
Tags
BEAM
Recent Press Releases
CRSP
From
Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, Here's How Much You Would Have Today
January 13, 2022
Tickers
NTLA
Tags
Dividends
Benzinga
BZI/POD
From
Benzinga
"Motley Fool Money" 2022 Investing Preview
January 07, 2022
Tickers
AAPL
AFRM
AI
AMWL
Tags
TSLA
AYX
TW
From
Motley Fool
What 4 Analyst Ratings Have To Say About Intellia Therapeutics
January 07, 2022
Tickers
NTLA
Tags
Market News
Analyst Ratings
NTLA
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
Tickers
ACVA
AER
AIN
ALC
Tags
ANF
TXRH
NTLA
From
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 05, 2022
Tickers
ACRX
ATXI
HOTH
KPRX
Tags
ACRX
BZI/TFM
KPRX
From
Benzinga
3 Healthcare Stocks That Could Rocket Higher in 2022
January 04, 2022
Tickers
ALGN
NTLA
REGN
SAVA
Tags
NTLA
SAVA
Market News
From
Motley Fool
Better Buy: CRISPR vs. Intellia
January 03, 2022
Tickers
BLUE
CRSP
NTLA
REGN
Tags
VRTX
BLUE
NTLA
From
Motley Fool
Top 5 Moonshots for 2022 Countdown: My No. 5 Pick
December 22, 2021
Tickers
BEAM
BTU
CRSP
EBAY
Tags
Market News
NTLA
SAFEMOON/USD
From
InvestorPlace
3 Healthcare Stocks That Could Double Next Year
December 10, 2021
Tickers
ALGN
ISRG
NTLA
Tags
NTLA
ALGN
Market News
From
Motley Fool
54 Biggest Movers From Yesterday
December 08, 2021
Tickers
ADAG
ADGI
AERI
ARQQ
Tags
IMPP
XYF
VAXX
From
Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
December 07, 2021
Tickers
AERI
AVAV
BIRD
BYSI
Tags
Small Cap
GTLB
AERI
From
Benzinga
Direxion Launches New Nanotechnology ETF, TYNE
November 23, 2021
Tickers
ALKS
ANGO
ARCT
BEAM
Tags
ALKS
BRKR
TYNE
From
ETF Trends
Do CRISPR Therapeutics and Intellia Face a Big Safety Risk?
November 21, 2021
Tickers
CRSP
NTLA
Tags
NTLA
Market News
CRSP
From
Motley Fool
Novartis Has $21B From Roche Stake Sale - Which Company Is On Its M&A Radar?
November 18, 2021
Tickers
ALNY
BIIB
BMRN
DRNA
Tags
RHHBF
NVS
Briefs
From
Benzinga
Intellia Therapeutics, Inc (NTLA) Q3 2021 Earnings Call Transcript
November 06, 2021
Tickers
NTLA
Tags
Recent Press Releases
NTLA
Market News
From
Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Tickers
AERI
ALGS
ALLO
ANIP
Tags
YMAB
NVAX
NVS
From
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
CMRX
HCWB
PEN
From
Benzinga
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
Tickers
CRSP
NTLA
REGN
VRTX
Tags
NTLA
Market News
CRSP
From
Motley Fool
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
October 21, 2021
Tickers
ARKG
BEAM
DIS
EXAS
Tags
SNY
NVTA
JNJ
From
Motley Fool
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
October 19, 2021
Tickers
EDIT
NTLA
Tags
NTLA
EDIT
Market News
From
InvestorPlace
EVP And Chief Medical Officer Of Intellia Therapeutics Trades $340K In Company Stock
October 18, 2021
Tickers
NTLA
Tags
Insider sells
Insider Trades
News
From
Benzinga
2 Gene-Editing Stocks to Have on Your Radar Right Now
October 17, 2021
Tickers
ARKG
ARKK
BEAM
CRSP
Tags
BEAM
ARKG
CRSP
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
SDGR
CRSP
BEAM
From
Motley Fool
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
October 15, 2021
Tickers
BLFS
EDIT
LZAGF
MRNA
Tags
NTLA
Market News
BLFS
From
Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.